Breaking News

Cenduit Launches New Trial Supply Service

December 5, 2012

Simulation and forecasting designed to better control supplies

Cenduit LLC has introduced a new study simulation and forecasting service designed to allow clinical trial sites to better plan and control supplies for patients. The new service is integrated with the company’s interactive response technology (IRT).
 
“Clinical trials are more complex than ever and a robust and reliable clinical trial supply strategy is vital to study success,” said Jogin Desai, Cenduit’s chief executive officer. “The simulation and forecasting models, integrated with the patient randomization and drug allocation services inherent in our IRT systems, allow the complete coordination of procurement, packaging and logistics, with supply requirements from the sites themselves continuously factored in.”
 
Mr. Desai added that new system helps minimize the risk of drug supply overage and shortages at sites and helps accelerate drug development through increased supply chain productivity.

Related Contract Manufacturing:

Related Packaging:

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research